C eramide and sphingosine-1-phosphate are related sphingolipid metabolites that can be generated through a de novo biosynthetic route or derived from the recycling of membrane sphingomyelin. Both these lipids regulate cellular responses to stress, with generally opposing effects. Sphingosine-1-phosphate functions as a growth and survival factor, acting as a ligand for a family of G protein-coupled receptors, whereas ceramide activates intrinsic and extrinsic apoptotic pathways through receptor-independent mechanisms. A growing body of evidence has implicated ceramide, sphingosine-1-phosphate and the genes involved in their synthesis, catabolism and signaling in various aspects of oncogenesis, cancer progression and drug-and radiation resistance. This may be explained in part by the finding that both lipids impinge upon the PI3K/ AKT pathway, which represses apoptosis and autophagy. In addition, sphingolipids influence cell cycle progression, telomerase function, cell migration and stem cell biology. Considering the central role of ceramide in mediating physiological as well as pharmacologically stimulated apoptosis, ceramide can be considered a tumor-suppressor lipid. In contrast, sphingosine-1-phosphate can be considered a tumor-promoting lipid, and the enzyme responsible for its synthesis functions as an oncogene. Not surprisingly, genetic mutations that result in reduced ceramide generation, increased sphingosine-1-phosphate synthesis or which reduce steady state ceramide levels and increase sphingosine-1-phosphate levels have been identified as mechanisms of tumor progression and drug resistance in cancer cells. Pharmacological tools for modulating sphingolipid pathways are being developed and represent novel therapeutic strategies for the treatment of cancer.
Introduction
Over the past twenty years, lipid metabolites have become recognized for their participation in membrane functions and signaling events that control a wide array of cellular activities. Two major sphingolipid metabolites, ceramide and sphingosine-1-phosphate (S1P), are involved in signaling pathways that regulate cell proliferation, apoptosis, motility, differentiation, stress responses, protein synthesis, carbohydrate metabolism, innate and adaptive immunity and angiogenesis. Ceramide and S1P exert opposing effects on cell survival, ceramide being pro-apoptotic and S1P generally promoting cell survival. In relation to their influence over cell fate, these two lipids and the proteins that mediate their signaling functions and metabolism have been implicated in various aspects of tumor biology and chemo-and radio-resistance. This review will summarize the main steps of sphingolipid metabolism and our current understanding of the interactions between ceramide, S1P and the cellular pathways that control cell fate. Recent in vitro and in vivo evidence supporting the roles these lipids play in oncogenesis, tumor progression and cancer therapeutics will be discussed. Readers interested in other aspects of sphingolipid metabolism and signaling are referred to several excellent recent review articles.
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Sphingolipid Metabolism
Ceramides are a class of hydrophobic molecules that contain a fatty acid moiety linked to sphingosine or a related long chain base.
8 Ceramides are the basic constituents of higher order sphingolipids and also serve as bioactive intermediates that promote cell death. Ceramide is generated via a de novo biosynthetic pathway that is initiated by a condensation reaction between serine and palmitoyl CoA catalyzed by the essential enzyme serine palmitoyltransferase (SPT), resulting in the formation of 3-oxo-sphinganine (Fig. 1) . The NADPH-dependent enzyme 3-oxo-sphinganine reductase converts 3-oxo-sphinganine to dihydrosphingosine. The latter is converted into dihydroceramide via an acylation reaction catalyzed by dihydroceramide synthase, encoded by the CerS genes, formerly known as LASS genes. Oxidation of dihydroceramide by dihydroceramide desaturase generates ceramide. Ceramide may be converted to sphingomyelin by sphingomyelin synthase, which catalyzes the transfer of phosphocholine from phosphatidylcholine to ceramide.
9 Alternatively, ceramide may be modified via the addition of carbohydrate groups at the carbon 1 position by glucosylceramide synthase or galactosyl ceramide synthase and subsequent biochemical steps to generate glycosphingolipids. Ceramide can also be generated through a recycling pathway known as the "sphingomyelin cycle".
10
This process involves the hydrolysis of plasma membrane sphingomyelin, yielding ceramide and Figure 1 . Sphingolipid metabolism. The de novo pathway for generation and degradation of sphingolipids is depicted along with the enzymes that catalyze each step and their inhibitors. SPT, serine-palmitoyl transferase; DHCD, dihydroceramide desaturase; SphK, sphigosine kinase; S1P P'ase, S1P phosphatase; GCS, glucosyl ceramide synthase; PPMP, 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol; PDMP, l-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol; DMS, dimethyl sphingosine; 4-HPR, N-(4-hydroxyphenyl) retinamide; OEA, oleylethanolamide; MAPP, 2-(N-myristoylamino)-1-phenyl-1-propanol.
